Developer docs
API playgroundTry for free, no card

Search company profiles

Spectrum Vascular

Full company profile

uuid0008b1w

Namestring
Spectrum Vascular
Legal namestring
Spectrum Vascular
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Spectrum Vascular is a privately held US medical device company headquartered in White Plains, New York, focused exclusively on vascular access and medication management products for hospitals and clinicians. The company was formed in 2023 by SK Capital Partners through the acquisition of Cook Medical's vascular access business, and subsequently added AngioDynamics' PICC and midline catheter product portfolios in February 2024 and Piccolo Medical in June 2026. Its commercial catalog spans central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, guidance hardware (ECGuide and SV NAV+), and accessories, supported by two proprietary technology platforms: Spectrum antimicrobial coating (minocycline/rifampin, targeting CLABSI/CRBSI reduction) and BioFlo Endexo-based thrombus-resistant polymer technology.

The company's technical differentiation rests on three layers: antimicrobial and anti-thrombogenic catheter materials acquired from Cook and AngioDynamics; a 510(k)-cleared ECG-based catheter tip location system (ECGuide); and a proprietary blood-flow-sensing catheter navigation platform (SV NAV+ / Nav+ Stylet) developed by Piccolo Medical and now integrated post-acquisition. Clinical evidence supporting the antimicrobial and thrombus-reduction claims is anchored in more than 30 peer-reviewed studies and meta-analyses referenced on the company site. Spectrum Vascular sells primarily through a direct US field sales organization (regional reps covering named US territories, plus dedicated VPs for US Corporate Accounts and International Sales) and through distribution partners in Canada (Canadian Hospital Specialties), the UK (Kimal), Ireland (Uniphar Medtech) and Mexico (Artimedia). It claims global reach across North America, Europe, the Middle East, Africa, Latin America and Asia Pacific, and pursues demand generation through vascular access and healthcare system conferences (AVA, Medica, Vizient Connections Summit, IDN Summit, Health Connect Partners, AAHVAP, Premier Breakthroughs) and an extensive peer-reviewed publication library.

The business model is hardware sales of single-use sterile devices to hospitals and integrated delivery networks, with revenue mechanics typical of medical device procurement (quote-based contracts, GPO/IDN agreements, distributor margins). The firm is closely held under SK Capital Partners, which has provided strategic equity and access to credit (Apogem Capital, Kayne Anderson Private Credit, KeyBank Beachpoint) to fund acquisitions and product development; the June 2026 Piccolo deal was financed with existing SK Capital-backed capital. The company is led by CEO Ken Miller, appointed in May 2025, with the Piccolo founding team integrated into Spectrum Vascular post-close.

Short descriptiontext

Spectrum Vascular is a PE-backed medical device company that designs, manufactures, and sells vascular access products, including antimicrobial and thrombus-resistant CVCs, PICCs, midlines, and next-generation catheter navigation systems, serving hospitals, healthcare systems, and clinicians globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWhite Plains, United States
HQ citystring
White Plains
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular access devices, central venous catheters, antimicrobial catheters, catheter navigation systems, PICC catheters
Industry2 codes
PRIMARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Vascular Access Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of vascular access devices including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, catheter guidance systems, and accessories. The company was formed through acquisitions of Cook Medical's and AngioDynamics' vascular access businesses.

spectrumvascular.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1SV NAV+
Description

Navigation platform for vascular access providing real-time catheter guidance using blood flow sensing technology

spectrumvascular.com
+2 more records
Core offering1 text field

Spectrum Vascular manufactures and sells a comprehensive portfolio of vascular access medical devices for hospitals and healthcare systems, including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, and catheter guidance systems (SV NAV+, ECGuide). The devices incorporate proprietary antimicrobial (SV Spectrum) and antithrombotic (SV BioFlo with Endexo) technologies designed to reduce catheter-related bloodstream infections and occlusions, and the SV NAV+/ECGuide navigation platform enables real-time catheter tip placement using proprietary blood flow sensing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Validated by over 30 peer-reviewed studies and meta-analysis
+3 more records
Product overview1 text field

Spectrum Vascular offers a comprehensive portfolio of vascular access and medication management products designed to reduce healthcare-acquired infections. The product lineup includes multiple catheter types (CVCs, PICCs, Midlines, Arterial Lines, IO Needles), catheter guidance systems (SV Guidance including SV NAV+ and ECGuide®), and accessories. Key technology platforms include Spectrum™ Technology (antimicrobial properties using minocycline and rifampin to reduce CLABSI/CRBSI) and BioFlo® Technology (thrombus-reducing properties using Endexo® technology). The recent acquisition of Piccolo Medical (June 2026) brings next-generation catheter navigation technology using proprietary blood flow sensing. Products are primarily sold under SV branded lines as well as legacy brands including BioFlo® (from AngioDynamics) and Xcela™ (from Cook Medical).

Product and service7 records
1SV CVCs
CategoryVascular Access Catheters
Description

Central Venous Catheters (CVCs) designed for vascular access in hospital settings, featuring antimicrobial protection technology (SV Spectrum). Used by hospitals and critical care settings for central venous access.

2SV PICCs
CategoryVascular Access Catheters
Description

Peripherally Inserted Central Catheters (PICCs) for medium to long-term vascular access, incorporating BioFlo technology for thrombus reduction and antimicrobial SV Spectrum options. Designed for hospitals, infusion centers, and home infusion providers.

3SV Midlines
CategoryVascular Access Catheters
Description

Midline catheters for intermediate-duration vascular access, designed to reduce complications and improve patient outcomes. Used in hospital and outpatient settings for patients requiring vascular access for therapy of moderate duration.

4SV Arterial Lines
CategoryVascular Access Catheters
Description

Arterial lines for continuous blood pressure monitoring and arterial access in critical care, operating room, and emergency settings. For use by hospitals and critical care clinicians.

5SV IO Needles
CategoryVascular Access Devices
Description

Intraosseous (IO) needles for emergency vascular access when traditional IV access is not feasible. Used by emergency medical services, emergency departments, and military/field medicine.

6SV Guidance (Catheter Guidance Systems including SV NAV+ and ECGuide)
CategoryCatheter Guidance and Navigation
Description

Catheter guidance and tip location systems including SV NAV+ (real-time blood flow sensing catheter navigation) and ECGuide (ECG-based tip location confirmation) that enable precise catheter tip placement and eliminate the need for confirmatory chest X-rays. For hospitals, vascular access teams, and interventional radiology.

7SV Accessories
CategoryVascular Access Accessories
Description

Accessory products supporting vascular access procedures including connectors, caps, and other supporting equipment for catheter placement and maintenance. For hospitals and clinical care facilities.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Spectrum Vascular acquired Piccolo Medical in June 2026. Piccolo's CEO Augustus Shanahan and the team joined Spectrum to advance development and commercialization of 510(k)-cleared catheter guidance technologies. Piccolo was founded in 2016 as a spinout of Theranova incubator, funded by private investors and grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Canadian Hospital Specialties Limited serves as Spectrum Vascular's distribution partner in Canada, expanding the company's geographic reach into the Canadian market for vascular access products.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Artimedia in Mexico provides training support for Spectrum Vascular products, expanding the company's presence in the Mexican market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

UK-based Kimal serves as Spectrum Vascular's distribution partner in the United Kingdom, providing local market access and training support for BioFlo products.

5Uniphar Medtech
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Uniphar Medtech operates as a business partner providing training and collaboration support for Spectrum Vascular products in Ireland.

spectrumvascular.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

BD is the global market leader in vascular access (PICCs, CVCs, midline catheters) through its BD Medical segment, and competes directly with Spectrum across the same product categories sold to hospitals and GPOs. Its scale, clinical evidence, and contracts make it the dominant benchmark competitor for Spectrum.

TypeDirect peer
Description

Teleflex owns the Arrow brand of central venous catheters, PICCs, and tip-location guidance systems, making it the closest direct peer to Spectrum's combined vascular access and catheter guidance portfolio. Arrow's installed base in US hospital ICUs is the primary competitive threat Spectrum must displace.

TypeBroad incumbent
Description

ICU Medical acquired Smiths Medical, adding a meaningful vascular access and catheter portfolio alongside its core infusion therapy business. It competes with Spectrum across CVCs, PICCs, and accessories, particularly in US hospital systems where combined contracts for infusion plus vascular access are common.

TypeBroad incumbent
Description

B. Braun is a global medical device manufacturer with a broad vascular access portfolio including CVCs, PICCs, midlines, and accessories, plus an integrated infusion therapy line. It competes with Spectrum across the same hospital call points, particularly in Europe and the US integrated delivery network segment.

TypeDirect peer
Description

AngioDynamics sold its PICC and midline catheter product portfolios (BioFlo and Xcela lines) to Spectrum Vascular in February 2024, but continues to operate in adjacent vascular and oncology access. Its remaining thrombus-management and dialysis product lines still address overlapping hospital decision-makers.

6Cook Medical
TypeBroad incumbent
Description

Cook Medical sold its vascular access business to Spectrum in 2023 but continues to operate broadly in interventional radiology, urology, and surgical devices. It retains the Spectrum antimicrobial technology trademark license to Spectrum Vascular, making it a former parent and licensing counterparty with continuing commercial overlap.

TypeDirect peer
Description

Vygon is a privately held French medical device company specializing in single-use vascular access products including PICCs, CVCs, and neonatal lines. It competes most directly with Spectrum in European and pediatric/neonatal segments, and is a likely candidate for further industry consolidation.

TypeEmerging player
Description

Merit Medical offers a portfolio of vascular access products including catheters and accessories, primarily through its Merit Sensor Systems and infusion products. While not a market leader in PICCs/CVCs, it competes in adjacent segments and is a potential acquirer of additional vascular access assets.

9Medline Industries
TypeBroad incumbent
Description

Medline is a large privately held medical supplies manufacturer and distributor with a broad vascular access catheter portfolio targeting US hospitals and GPOs. It competes with Spectrum primarily on price and contract terms across commodity catheter SKUs.

TypeRegional player
Description

PFM Medical is a privately held European medical device company offering vascular access and infusion therapy products, primarily serving Germany and select European markets. It overlaps with Spectrum's international expansion priorities and is comparable as a regional mid-tier vascular access player.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Spectrum Vascular

Vascular Access Medical Devicesspectrumvascular.com

Spectrum Vascular is a PE-backed medical device company that designs, manufactures, and sells vascular access products, including antimicrobial and thrombus-resistant CVCs, PICCs, midlines, and next-generation catheter navigation systems, serving hospitals, healthcare systems, and clinicians globally.

What Spectrum Vascular does

Spectrum Vascular is a privately held US medical device company headquartered in White Plains, New York, focused exclusively on vascular access and medication management products for hospitals and clinicians. The company was formed in 2023 by SK Capital Partners through the acquisition of Cook Medical's vascular access business, and subsequently added AngioDynamics' PICC and midline catheter product portfolios in February 2024 and Piccolo Medical in June 2026. Its commercial catalog spans central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, guidance hardware (ECGuide and SV NAV+), and accessories, supported by two proprietary technology platforms: Spectrum antimicrobial coating (minocycline/rifampin, targeting CLABSI/CRBSI reduction) and BioFlo Endexo-based thrombus-resistant polymer technology.

The company's technical differentiation rests on three layers: antimicrobial and anti-thrombogenic catheter materials acquired from Cook and AngioDynamics; a 510(k)-cleared ECG-based catheter tip location system (ECGuide); and a proprietary blood-flow-sensing catheter navigation platform (SV NAV+ / Nav+ Stylet) developed by Piccolo Medical and now integrated post-acquisition. Clinical evidence supporting the antimicrobial and thrombus-reduction claims is anchored in more than 30 peer-reviewed studies and meta-analyses referenced on the company site. Spectrum Vascular sells primarily through a direct US field sales organization (regional reps covering named US territories, plus dedicated VPs for US Corporate Accounts and International Sales) and through distribution partners in Canada (Canadian Hospital Specialties), the UK (Kimal), Ireland (Uniphar Medtech) and Mexico (Artimedia). It claims global reach across North America, Europe, the Middle East, Africa, Latin America and Asia Pacific, and pursues demand generation through vascular access and healthcare system conferences (AVA, Medica, Vizient Connections Summit, IDN Summit, Health Connect Partners, AAHVAP, Premier Breakthroughs) and an extensive peer-reviewed publication library.

The business model is hardware sales of single-use sterile devices to hospitals and integrated delivery networks, with revenue mechanics typical of medical device procurement (quote-based contracts, GPO/IDN agreements, distributor margins). The firm is closely held under SK Capital Partners, which has provided strategic equity and access to credit (Apogem Capital, Kayne Anderson Private Credit, KeyBank Beachpoint) to fund acquisitions and product development; the June 2026 Piccolo deal was financed with existing SK Capital-backed capital. The company is led by CEO Ken Miller, appointed in May 2025, with the Piccolo founding team integrated into Spectrum Vascular post-close.

Spectrum Vascular firmographics

Firmographics
Name
Spectrum Vascular
Legal name
Spectrum Vascular
Website
https://spectrumvascular.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
51–100 employees
Short description
Spectrum Vascular is a PE-backed medical device company that designs, manufactures, and sells vascular access products, including antimicrobial and thrombus-resistant CVCs, PICCs, midlines, and next-generation catheter navigation systems, serving hospitals, healthcare systems, and clinicians globally.
Ownership category
akta.pro rank

Spectrum Vascular industry classification

Industry
Product category
Vascular Access Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Vascular access devices
  • Central venous catheters
  • Antimicrobial catheters
  • Catheter navigation systems
  • PICC catheters

Where Spectrum Vascular is headquartered

Location

Headquarters

HQ city
White Plains
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Spectrum Vascular business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of vascular access devices including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, catheter guidance systems, and accessories. The company was formed through acquisitions of Cook Medical's and AngioDynamics' vascular access businesses.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Spectrum Vascular product offering

Product offering

Core offering

Spectrum Vascular manufactures and sells a comprehensive portfolio of vascular access medical devices for hospitals and healthcare systems, including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, and catheter guidance systems (SV NAV+, ECGuide). The devices incorporate proprietary antimicrobial (SV Spectrum) and antithrombotic (SV BioFlo with Endexo) technologies designed to reduce catheter-related bloodstream infections and occlusions, and the SV NAV+/ECGuide navigation platform enables real-time catheter tip placement using proprietary blood flow sensing.

Product overview

Spectrum Vascular offers a comprehensive portfolio of vascular access and medication management products designed to reduce healthcare-acquired infections. The product lineup includes multiple catheter types (CVCs, PICCs, Midlines, Arterial Lines, IO Needles), catheter guidance systems (SV Guidance including SV NAV+ and ECGuide®), and accessories. Key technology platforms include Spectrum™ Technology (antimicrobial properties using minocycline and rifampin to reduce CLABSI/CRBSI) and BioFlo® Technology (thrombus-reducing properties using Endexo® technology). The recent acquisition of Piccolo Medical (June 2026) brings next-generation catheter navigation technology using proprietary blood flow sensing. Products are primarily sold under SV branded lines as well as legacy brands including BioFlo® (from AngioDynamics) and Xcela™ (from Cook Medical).

Differentiator

Problem solved

Functional benefit

Brands

  • SV NAV+: Navigation platform for vascular access providing real-time catheter guidance using blood flow sensing technology
  • Cook Spectrum Technology
  • BioFlo

Products and services

  • SV CVCs Central Venous Catheters (CVCs) designed for vascular access in hospital settings, featuring antimicrobial protection technology (SV Spectrum). Used by hospitals and critical care settings for central venous access.
  • SV PICCs Peripherally Inserted Central Catheters (PICCs) for medium to long-term vascular access, incorporating BioFlo technology for thrombus reduction and antimicrobial SV Spectrum options. Designed for hospitals, infusion centers, and home infusion providers.
  • SV Midlines Midline catheters for intermediate-duration vascular access, designed to reduce complications and improve patient outcomes. Used in hospital and outpatient settings for patients requiring vascular access for therapy of moderate duration.
  • SV Arterial Lines Arterial lines for continuous blood pressure monitoring and arterial access in critical care, operating room, and emergency settings. For use by hospitals and critical care clinicians.
  • SV IO Needles Intraosseous (IO) needles for emergency vascular access when traditional IV access is not feasible. Used by emergency medical services, emergency departments, and military/field medicine.
  • SV Guidance (Catheter Guidance Systems including SV NAV+ and ECGuide) Catheter guidance and tip location systems including SV NAV+ (real-time blood flow sensing catheter navigation) and ECGuide (ECG-based tip location confirmation) that enable precise catheter tip placement and eliminate the need for confirmatory chest X-rays. For hospitals, vascular access teams, and interventional radiology.
  • SV Accessories Accessory products supporting vascular access procedures including connectors, caps, and other supporting equipment for catheter placement and maintenance. For hospitals and clinical care facilities.

Quantifiable outcome

  • Validated by over 30 peer-reviewed studies and meta-analysis
  • +3 more outcomes

Companies that use Spectrum Vascular

Customer profile

Segments2 records

Ideal customer profiles1 record

Spectrum Vascular technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Spectrum Vascular partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Piccolo MedicalcoreStrategic or Co-development Partner · 1 June 2026Spectrum Vascular acquired Piccolo Medical in June 2026. Piccolo's CEO Augustus Shanahan and the team joined Spectrum to advance development and commercialization of 510(k)-cleared catheter guidance technologies. Piccolo was founded in 2016 as a spinout of Theranova incubator, funded by private investors and grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
  • Canadian Hospital Specialties LimitedcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Canadian Hospital Specialties Limited serves as Spectrum Vascular's distribution partner in Canada, expanding the company's geographic reach into the Canadian market for vascular access products.
  • ArtimediaminorChannel Partner/ Reseller/ Distributor · 1 January 2025Artimedia in Mexico provides training support for Spectrum Vascular products, expanding the company's presence in the Mexican market.
  • KimalcoreChannel Partner/ Reseller/ Distributor · 1 January 2024UK-based Kimal serves as Spectrum Vascular's distribution partner in the United Kingdom, providing local market access and training support for BioFlo products.
  • Uniphar MedtechcoreChannel Partner/ Reseller/ Distributor · 1 January 2024Uniphar Medtech operates as a business partner providing training and collaboration support for Spectrum Vascular products in Ireland.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Spectrum Vascular competitors and assessment

Company assessment

Broad incumbents

  • BD (Becton, Dickinson and Company): BD is the global market leader in vascular access (PICCs, CVCs, midline catheters) through its BD Medical segment, and competes directly with Spectrum across the same product categories sold to hospitals and GPOs. Its scale, clinical evidence, and contracts make it the dominant benchmark competitor for Spectrum.
  • ICU Medical: ICU Medical acquired Smiths Medical, adding a meaningful vascular access and catheter portfolio alongside its core infusion therapy business. It competes with Spectrum across CVCs, PICCs, and accessories, particularly in US hospital systems where combined contracts for infusion plus vascular access are common.
  • B. Braun Medical: B. Braun is a global medical device manufacturer with a broad vascular access portfolio including CVCs, PICCs, midlines, and accessories, plus an integrated infusion therapy line. It competes with Spectrum across the same hospital call points, particularly in Europe and the US integrated delivery network segment.
  • Cook Medical: Cook Medical sold its vascular access business to Spectrum in 2023 but continues to operate broadly in interventional radiology, urology, and surgical devices. It retains the Spectrum antimicrobial technology trademark license to Spectrum Vascular, making it a former parent and licensing counterparty with continuing commercial overlap.
  • Medline Industries: Medline is a large privately held medical supplies manufacturer and distributor with a broad vascular access catheter portfolio targeting US hospitals and GPOs. It competes with Spectrum primarily on price and contract terms across commodity catheter SKUs.

Direct peers

  • Teleflex: Teleflex owns the Arrow brand of central venous catheters, PICCs, and tip-location guidance systems, making it the closest direct peer to Spectrum's combined vascular access and catheter guidance portfolio. Arrow's installed base in US hospital ICUs is the primary competitive threat Spectrum must displace.
  • AngioDynamics: AngioDynamics sold its PICC and midline catheter product portfolios (BioFlo and Xcela lines) to Spectrum Vascular in February 2024, but continues to operate in adjacent vascular and oncology access. Its remaining thrombus-management and dialysis product lines still address overlapping hospital decision-makers.
  • Vygon: Vygon is a privately held French medical device company specializing in single-use vascular access products including PICCs, CVCs, and neonatal lines. It competes most directly with Spectrum in European and pediatric/neonatal segments, and is a likely candidate for further industry consolidation.

Emerging players

  • Merit Medical Systems: Merit Medical offers a portfolio of vascular access products including catheters and accessories, primarily through its Merit Sensor Systems and infusion products. While not a market leader in PICCs/CVCs, it competes in adjacent segments and is a potential acquirer of additional vascular access assets.

Regional players

  • PFM Medical: PFM Medical is a privately held European medical device company offering vascular access and infusion therapy products, primarily serving Germany and select European markets. It overlaps with Spectrum's international expansion priorities and is comparable as a regional mid-tier vascular access player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Spectrum Vascular social profiles

Digital presence

Spectrum Vascular financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Spectrum Vascular leadership team

Management profile

Number of profiles

Profiles6 records

Spectrum Vascular subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Spectrum Vascular funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Spectrum Vascular M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spectrum Vascular

What does Spectrum Vascular do?

Spectrum Vascular manufactures and sells a comprehensive portfolio of vascular access medical devices for hospitals and healthcare systems, including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, intraosseous needles, and catheter guidance systems (SV NAV+, ECGuide). The devices incorporate proprietary antimicrobial (SV Spectrum) and antithrombotic (SV BioFlo with Endexo) technologies designed to reduce catheter-related bloodstream infections and occlusions, and the SV NAV+/ECGuide navigation platform enables real-time catheter tip placement using proprietary blood flow sensing.

Is Spectrum Vascular a public or private company?

Spectrum Vascular is a private company. It is classified as private equity controlled and is currently operating.

When was Spectrum Vascular founded?

Spectrum Vascular was founded in 2023. It employs 51 to 100 people.

Where is Spectrum Vascular based?

Spectrum Vascular is headquartered in White Plains, United States, in the North America region.

How does Spectrum Vascular make money?

One revenue line is on record: medical Device Sales.

Who are Spectrum Vascular's main competitors?

Broad incumbents on record are BD (Becton, Dickinson and Company), ICU Medical, B. Braun Medical, Cook Medical and Medline Industries. Direct peers are Teleflex, AngioDynamics and Vygon. Merit Medical Systems is listed as an emerging player. PFM Medical is listed as a regional player.

Does Spectrum Vascular have an API?

No public API is recorded for Spectrum Vascular.

What industry is Spectrum Vascular in?

Spectrum Vascular's product category is Vascular Access Medical Devices. Its primary akta.pro industry code is HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TodaysmedicaldevelopmentsMedtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires MasimoSpectrum Vascular announced the acquisition of Piccolo Medical, a developer of catheter guidance products, with Piccolo's CEO and team joining Spectrum to advance the development and commercialization of next-generation catheter navigation technology. Separately, Danaher Corp. completed its acquisition of Masimo Corp., making Masimo a wholly-owned subsidiary and removing it from Nasdaq trading, with Masimo operating as a stand-alone entity within Danaher's Diagnostics segment. Both transactions represent strategic moves to expand product portfolios and market reach in the medical technology sector.Pulse 2.0Spectrum Vascular Acquires Piccolo MedicalSpectrum Vascular announced the acquisition of Piccolo Medical, a developer of catheter guidance technologies, with Piccolo CEO Augustus Shanahan and the company's team joining Spectrum to continue developing and commercializing Piccolo's 510(k)-cleared catheter guidance technologies. Piccolo's technology uses proprietary blood flow sensing to provide real-time catheter guidance and precise tip placement, eliminating the need for confirmatory chest X-rays, with first successful patient placements achieved in May 2026. The combined organization aims to establish a new standard of care in vascular access by integrating Piccolo's navigation technology with Spectrum's existing catheter portfolio and accelerating commercialization of the platform.citybizSpectrum Vascular Acquires Piccolo Medical to Expand Catheter Navigation PlatformSpectrum Vascular, a White Plains, New York-based medical device company backed by private investment firm SK Capital Partners, has acquired San Francisco-based Piccolo Medical for an undisclosed amount. The acquisition centers on Piccolo's catheter guidance technology, which uses proprietary blood-flow sensing to assist clinicians with real-time catheter tip placement and eliminate the need for confirmatory chest X-rays. The combined company plans to integrate Piccolo's navigation technology with Spectrum's existing catheter products to create a more comprehensive vascular access platform addressing both device placement and ongoing catheter management.AijournSpectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation TechnologySpectrum Vascular, a leading provider of vascular access and medication management products, has acquired Piccolo Medical, a developer of catheter guidance technology, to accelerate the launch of next-generation catheter navigation products. Piccolo's real-time guidance system uses proprietary blood flow sensing technology to precisely guide catheter tip placement, eliminating the need for confirmatory chest X-rays. The combined entity, with Piccolo's leadership team including CEO Augustus Shanahan joining Spectrum, aims to set a new standard of care in vascular access and scale commercialization globally.PR NewswireSpectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation TechnologySpectrum Vascular announced the acquisition of Piccolo Medical, a developer of catheter guidance technology, to enhance its vascular access solutions. The deal aims to accelerate the development and market launch of next-generation catheter navigation products that use real-time blood flow sensing technology.MassDeviceSpectrum Vascular acquires catheter guidance tech developer Piccolo MedicalSpectrum Vascular announced the acquisition of catheter guidance product developer Piccolo Medical to deepen their partnership and bring next-generation catheter guidance technology to market. Piccolo's CEO Augustus Shanahan and the legacy team will join Spectrum, which plans to advance development and commercialization of Piccolo's FDA-cleared catheter guidance and location products. The combined entity aims to accelerate commercialization, integrate with Spectrum's existing catheter portfolio, and scale the next-generation navigation platform.PiccolomedicalSpectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology — Piccolo MedicalSpectrum Vascular acquired Piccolo Medical, a developer of catheter guidance products, to accelerate next-generation catheter navigation technology. Piccolo's 510(k)-cleared guidance products use blood flow sensing to eliminate confirmatory chest X-rays, with first patient placements completed in May 2026. The combined organization will accelerate commercialization and integrate with Spectrum's vascular access portfolio.BioSpaceSpectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation TechnologySpectrum Vascular acquired Piccolo Medical, a developer of catheter guidance products, to accelerate next-generation catheter navigation technology. Piccolo's real-time guidance uses blood flow sensing to eliminate confirmatory chest X-rays, with first patient placements completed in May 2026. The combined organization will scale the navigation platform and integrate with Spectrum's vascular access portfolio.SpectrumvascularSpectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology – Spectrum VascularSpectrum Vascular acquired Piccolo Medical, a developer of catheter guidance products, to accelerate next-generation catheter navigation technology. Piccolo's 510(k)-cleared products use blood flow sensing to guide catheter placement without confirmatory X-rays, with first patient placements completed in May 2026. The combined organization will scale the navigation platform and integrate with Spectrum's vascular access portfolio.MassDeviceSpectrum Vascular bolsters executive team with new CEO, CCOSpectrum Vascular appointed Ken Miller as CEO and Doug Shook as CCO to advance its mission following a strategic investment by SK Capital. The company, formed through the acquisition of vascular access businesses from Cook Medical and AngioDynamics, aims to leverage this leadership change to expand market presence and improve patient outcomes.